Ken Macnamara is the founder of Trogenix. Trogenix has raised $111M in total funding. Latest round: Series A. Based in Edinburgh, United Kingdom.
Ken Macnamara is the Chief Executive Officer of Trogenix, a clinical-stage biotech company focused on developing precision genetic medicine for solid tumors. Trogenix recently announced a $95 million Series A financing round to accelerate its clinical trials and advance its Odysseus platform.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide